title: In vitro and in vivo biocompatibility of apatite-coated magnetite nanoparticles for cancer therapy.
abstract: The aim of this study was to determine the biocompatibility and potential toxicity of apatite-coated magnetite nanoparticles. The in vitro biocompatibility with human red blood cells was evaluated, not hemolytic effects were found at concentrations lower than 3 mg/ml. For the in vivo study, Balb/c mice were used. The animals were injected intravenously or intraperitoneally, the doses ranged from 100 to 2,500 mg/Kg. All the injected animals showed normal kidney and liver function. No significant changes were found in the body weight, the organs weight and the iron levels in liver due to the administration. In conclusion, apatite-coated magnetite nanoparticles did not induce any abnormal clinical signs in the laboratory animals. The results demonstrated that apatite-coated magnetite nanoparticles of 8 ± 2 nm in size did not have hemolytic effect in human erythrocytes and did not cause apparent toxicity in Balb/c mice under the experimental conditions of this study.
authors: CINVESTAV IPN-Unidad Saltillo, Saltillo, Ramos Arizpe, COAH, Mexico. emuzquiz@uadec.edu.mx
authors: Elia Martha
authors: EM
authors: Múzquiz-Ramos
authors: D A
authors: DA
authors: Cortés-Hernández
authors: J C
authors: JC
authors: Escobedo-Bocardo
authors: Alejandro
authors: A
authors: Zugasti-Cruz
authors: X S
authors: XS
authors: Ramírez-Gómez
authors: J G
authors: JG
authors: Osuna-Alarcón
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001031:Apatites; D001672:Biocompatible Materials; D005260:Female; D052203:Ferrosoferric Oxide; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D053758:Nanoparticles; D009929:Organ Size / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D001031:Apatites; D001672:Biocompatible Materials; D052203:Ferrosoferric Oxide
references: Biomaterials. 2010 Apr;31(10):2746-54
references: 20044132
references: Biomaterials. 1999 Nov;20(22):2193-8
references: 10555088
references: Mol Pharm. 2008 Mar-Apr;5(2):316-27
references: 18217714
references: J Electron Microsc (Tokyo). 2010;59(2):173-9
references: 19897510
references: Mol Pharm. 2008 Jul-Aug;5(4):487-95
references: 18510338
references: J Biomed Mater Res. 1990 Jun;24(6):721-34
references: 2361964
references: Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504
references: 17116343
references: World J Gastroenterol. 2009 Jun 28;15(24):2995-3002
references: 19554652